annual EBIT:
$353.29M+$90.25M(+34.31%)Summary
- As of today (August 16, 2025), AMRX annual earnings before interest & taxes is $353.29 million, with the most recent change of +$90.25 million (+34.31%) on December 31, 2024.
- During the last 3 years, AMRX annual EBIT has risen by +$128.97 million (+57.50%).
- AMRX annual EBIT is now -11.61% below its all-time high of $399.71 million, reached on December 1, 2010.
Performance
AMRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$116.81M+$22.39M(+23.71%)Summary
- As of today (August 16, 2025), AMRX quarterly earnings before interest & taxes is $116.81 million, with the most recent change of +$22.39 million (+23.71%) on June 30, 2025.
- Over the past year, AMRX quarterly EBIT has increased by +$30.69 million (+35.63%).
- AMRX quarterly EBIT is now at all-time high.
Performance
AMRX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$338.51M+$30.69M(+9.97%)Summary
- As of today (August 16, 2025), AMRX TTM earnings before interest & taxes is $338.51 million, with the most recent change of +$30.69 million (+9.97%) on June 30, 2025.
- Over the past year, AMRX TTM EBIT has increased by +$212.26 million (+168.11%).
- AMRX TTM EBIT is now at all-time high.
Performance
AMRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AMRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.3% | +35.6% | +168.1% |
| 3 y3 years | +57.5% | +159.3% | +373.7% |
| 5 y5 years | +10000.0% | +683.4% | +186.0% |
AMRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +76.3% | at high | +159.3% | at high | +373.7% |
| 5 y | 5-year | at high | >+9999.0% | at high | +159.3% | at high | +373.7% |
| alltime | all time | -11.6% | +1485.8% | at high | +151.7% | at high | +252.4% |
AMRX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $116.81M(+23.7%) | $338.51M(+10.0%) |
| Mar 2025 | - | $94.42M(+103.8%) | $307.83M(+51.2%) |
| Dec 2024 | $353.29M(+34.3%) | $46.34M(-42.7%) | $203.58M(+52.7%) |
| Sep 2024 | - | $80.93M(-6.0%) | $133.33M(+5.6%) |
| Jun 2024 | - | $86.12M(-977.1%) | $126.26M(+4.6%) |
| Mar 2024 | - | -$9.82M(-58.9%) | $120.65M(-29.2%) |
| Dec 2023 | $263.04M(+31.2%) | -$23.91M(-132.4%) | $170.36M(-27.1%) |
| Sep 2023 | - | $73.87M(-8.3%) | $233.65M(+14.3%) |
| Jun 2023 | - | $80.52M(+101.9%) | $204.35M(-378.9%) |
| Mar 2023 | - | $39.89M(+1.3%) | -$73.28M(-18.4%) |
| Dec 2022 | $200.43M(-10.6%) | $39.37M(-11.7%) | -$89.75M(-19.5%) |
| Sep 2022 | - | $44.57M(-122.6%) | -$111.48M(-9.9%) |
| Jun 2022 | - | -$197.11M(-941.8%) | -$123.70M(-186.9%) |
| Mar 2022 | - | $23.41M(+32.7%) | $142.32M(-15.1%) |
| Dec 2021 | $224.31M(+43.5%) | $17.64M(-45.5%) | $167.69M(-6.4%) |
| Sep 2021 | - | $32.36M(-53.0%) | $179.11M(+12.1%) |
| Jun 2021 | - | $68.91M(+41.2%) | $159.76M(+51.1%) |
| Mar 2021 | - | $48.79M(+67.9%) | $105.76M(-4.0%) |
| Dec 2020 | $156.31M(>+9900.0%) | $29.06M(+123.4%) | $110.22M(+75.3%) |
| Sep 2020 | - | $13.01M(-12.8%) | $62.88M(-46.9%) |
| Jun 2020 | - | $14.91M(-72.0%) | $118.36M(+29.9%) |
| Mar 2020 | - | $53.24M(-391.2%) | $91.11M(-275.1%) |
| Dec 2019 | $1.51M | -$18.28M(-126.7%) | -$52.04M(+816.0%) |
| Sep 2019 | - | $68.48M(-654.9%) | -$5.68M(-33.7%) |
| Jun 2019 | - | -$12.34M(-86.3%) | -$8.57M(-96.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$89.90M(-420.2%) | -$222.12M(+275.5%) |
| Dec 2018 | $300.78M(+22.4%) | $28.07M(-57.2%) | -$59.15M(+1038.8%) |
| Sep 2018 | - | $65.59M(-129.0%) | -$5.19M(-79.4%) |
| Jun 2018 | - | -$225.88M(-409.1%) | -$25.18M(-109.8%) |
| Mar 2018 | - | $73.07M(-10.9%) | $258.03M(+39.5%) |
| Dec 2017 | $245.71M(+444.6%) | $82.03M(+79.9%) | $184.96M(+79.7%) |
| Sep 2017 | - | $45.60M(-20.5%) | $102.93M(+79.5%) |
| Jun 2017 | - | $57.33M | $57.33M |
| Dec 2016 | $45.12M(-48.4%) | - | - |
| Dec 2015 | $87.44M(-9.9%) | - | - |
| Dec 2014 | $97.05M(+301.7%) | - | - |
| Dec 2013 | $24.16M(-74.0%) | - | - |
| Dec 2012 | $92.76M(-13.4%) | - | - |
| Dec 2011 | $107.12M(-73.2%) | - | - |
| Dec 2010 | $399.71M(+369.6%) | - | - |
| Dec 2009 | $85.11M(+621.6%) | - | - |
| Dec 2008 | $11.79M(-86.4%) | - | - |
| Dec 2007 | $86.53M(+8535.9%) | - | - |
| Dec 2006 | $1.00M(-52.5%) | - | - |
| Dec 2005 | $2.11M(-118.9%) | - | - |
| Dec 2003 | -$11.20M(-46.1%) | - | - |
| Dec 2002 | -$20.76M(-18.6%) | - | - |
| Dec 2001 | -$25.49M(+17.2%) | - | - |
| Dec 2000 | -$21.75M(+172.0%) | - | - |
| Dec 1999 | -$8.00M(+58.5%) | - | - |
| Dec 1998 | -$5.05M | - | - |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of AMRX is $353.29M
What is the all time high annual EBIT for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $399.71M
What is Amneal Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, AMRX annual earnings before interest & taxes has changed by +$90.25M (+34.31%)
What is Amneal Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AMRX is $116.81M
What is the all time high quarterly EBIT for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $116.81M
What is Amneal Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, AMRX quarterly earnings before interest & taxes has changed by +$30.69M (+35.63%)
What is Amneal Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AMRX is $338.51M
What is the all time high TTM EBIT for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $338.51M
What is Amneal Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, AMRX TTM earnings before interest & taxes has changed by +$212.26M (+168.11%)